globe

Our Clients

client logoclient logoclient logoclient logoclient logoclient logoclient logoclient logoclient logoclient logo
`

Our Numbers Speak Volumes

40 +

Products

15 + Countries

Global Exports

100 +

Clients

50 MT/Month

Manufacturing Capability

10 +

Years Of Experience

Our Core Values

C

Building strong, long-term relationships with clients and stakeholders.

Customer Focus
R

Include dependability, consistency, accountability, honesty, and commitment.

Reliability
E

Striving for continuous improvement in people, processes, and performance.

Excellence
D

Committing fully to goals despite obstacles, reflecting a deep personal drive to achieve success.

Determination
O

Build a culture of reliability by investing in robust systems, providing high-quality services, and focusing on customer

Organizations

Want The Latest Industry News, Updates And More, Curated For You?

Key Milestones

Credo Life Sciences Incorporated

Credo Life Sciences was incorporated in July 2014, laying the foundation for a vision-driven organization focused on innovative pharmaceutical solutions. This marked the beginning of our journey to build a strong presence in global healthcare.

The incorporation set the stage for a company rooted in quality, research, and global aspirations, evolving into a trusted name in advanced formulations and drug delivery technologies.

Milestonecredo
Capsule
Credo Life Sciences Incorporated 2014
Capsule
Commercial Operations Commenced 2017
Capsule
Achieved GMP Certification 2018
Capsule
Secured WHO-GMP Approval 2019
Capsule
Russian MOH Filing 2020
Capsule
Earned EU-GMP Certification 2023
Capsule
Earned SFDA Certification 2024

News & Updates

Blog 1

Pharma Outlook Book Feature

Our state-of-the-art facility has been highlighted in the renowned Pharma Outlook Book, a testament to our growing presence and recognition in the international pharmaceutical landscape. This feature underscores our dedication to innovation, compliance, and delivering high-quality pharmaceutical solutions.

Read More
Blog 2

CPHI Frankfurt

We are delighted to announce our participation in CPhI Worldwide, Frankfurt, Germany (28-30 October 2025), showcasing our capabilities at the heart of global pharma innovation. Our Stand #12.1A90

Read More
Blog 3

Pivotal Clinical Studies

Our pivotal bioequivalence (BE) studies are now available for advanced formulations, including:
Duloxetine HCL EC Pellets 17%
Venlafaxine HCL SR Pellets 33%

Read More

Our Corporate Video

Contact Us

assist